Literature DB >> 31259008

Learning to Identify Patients at Risk of Uncontrolled Hypertension Using Electronic Health Records Data.

Ramin Mohammadi1,2, Sarthak Jain1, Stephen Agboola2,3, Ramya Palacholla2,3, Sagar Kamarthi1,2, Byron C Wallace1.   

Abstract

Hypertension is a major risk factor for stroke, cardiovascular disease, and end-stage renal disease, and its prevalence is expected to rise dramatically. Effective hypertension management is thus critical. A particular priority is decreasing the incidence of uncontrolled hypertension. Early identification of patients at risk for uncontrolled hypertension would allow targeted use of personalized, proactive treatments. We develop machine learning models (logistic regression and recurrent neural networks) to stratify patients with respect to the risk of exhibiting uncontrolled hypertension within the coming three-month period. We trained and tested models using EHR data from 14,407 and 3,009 patients, respectively. The best model achieved an AUROC of 0.719, outperforming the simple, competitive baseline of relying prediction based on the last BP measure alone (0.634). Perhaps surprisingly, recurrent neural networks did not outperform a simple logistic regression for this task, suggesting that linear models should be included as strong baselines for predictive tasks using EHR.

Entities:  

Year:  2019        PMID: 31259008      PMCID: PMC6568059     

Source DB:  PubMed          Journal:  AMIA Jt Summits Transl Sci Proc


  2 in total

Review 1.  Artificial Intelligence and Hypertension: Recent Advances and Future Outlook.

Authors:  Thanat Chaikijurajai; Luke J Laffin; Wai Hong Wilson Tang
Journal:  Am J Hypertens       Date:  2020-11-03       Impact factor: 3.080

2.  Neural Network-Based Algorithm for Adjusting Activity Targets to Sustain Exercise Engagement Among People Using Activity Trackers: Retrospective Observation and Algorithm Development Study.

Authors:  Ramin Mohammadi; Mursal Atif; Amanda Jayne Centi; Stephen Agboola; Kamal Jethwani; Joseph Kvedar; Sagar Kamarthi
Journal:  JMIR Mhealth Uhealth       Date:  2020-09-08       Impact factor: 4.773

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.